333 Decarie boulevard
Suite 200 St-Laurent
Montreal, QC H4N 3M9
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees:
|Mr. Zohar Krivorot||Founder, Pres, CEO & Chairman||N/A||N/A||1978|
|Mr. Nicholas Sosiak C.A., CPA||Chief Financial Officer||163.68k||N/A||N/A|
|Avi Krivorot||Chief Technology Officer||70.43k||N/A||N/A|
|Mr. Anthony Manouk||VP Compliance & GM||N/A||N/A||N/A|
|Mr. David Abitbol||VP of Marketing||N/A||N/A||N/A|
|Ms. Julia Bouvet||Chief of Staff||N/A||N/A||N/A|
|Alexander Wolfe||VP of Bus. Devel.||N/A||N/A||N/A|
|Etienne Ledoux||Exec. Officer||N/A||N/A||N/A|
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.
Cannara Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.